MedTrace Logo

WARD-Home - Continuous Monitoring of Vital Parameters After Discharge

NCT05223504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-06-28

No results posted yet for this study

Summary

The current pilot study aims to investigate the feasibility of wireless, continuous monitoring of patients in the days around discharge after an acute medical hospitalization, as well as occurrence of deviating vital signs in this patient group.

Conditions

  • Vital Sign
  • Clinical Deterioration

Interventions

DEVICE

Continuously monitoring

Included patients are monitored with WARD equipment during the last part of hospitalization and the first days after discharge. Monitoring will last for a maximum of eight days.

Sponsors & Collaborators

  • Technical University of Denmark

    collaborator OTHER

  • University Hospital Bispebjerg and Frederiksberg

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Vibeke R Eriksen, MD, PhD · Rigshospitalet, Denmark

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-06-15
Completion
2022-06-15

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05223504 on ClinicalTrials.gov